iRhythm(US:IRTC) ZACKS·2025-10-30 22:45Core Insights - iRhythm Technologies reported a quarterly loss of $0.06 per share, significantly better than the Zacks Consensus Estimate of a loss of $0.36, marking an earnings surprise of +83.33% [1] - The company achieved revenues of $192.88 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 4.97% and showing a year-over-year increase from $147.54 million [2] - iRhythm Technologies shares have increased by approximately 105.5% year-to-date, outperforming the S&P 500's gain of 17.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.09 on revenues of $196.15 million, and for the current fiscal year, it is -$1.71 on revenues of $725.26 million [7] - The estimate revisions trend for iRhythm Technologies was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical Info Systems industry, to which iRhythm Technologies belongs, is currently ranked in the top 21% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]